4.7 Article

Cannabinoid modulation of amygdala reactivity to social signals of threat in humans

Journal

JOURNAL OF NEUROSCIENCE
Volume 28, Issue 10, Pages 2313-2319

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.5603-07.2008

Keywords

THC; cannabinoid; fMRI; amygdala; fear; anxiety

Categories

Funding

  1. NIDA NIH HHS [DA009133, R90 DA023425, DA002812, R01 DA002812, DA023425, R01 DA009133, R03 DA024197-01, R03 DA024197, DA024197] Funding Source: Medline
  2. NIMH NIH HHS [K23 MH076198-03, MH076198, K23 MH076198] Funding Source: Medline

Ask authors/readers for more resources

The cannabinoid (CB) system is a key neurochemical mediator of anxiety and fear learning in both animals and humans. The anxiolytic effects of Delta(9)-tetrahydrocannabinol (THC), the primary psychoactive ingredient in cannabis, are believed to be mediated through direct and selective agonism of CB1 receptors localized within the basolateral amygdala, a critical brain region for threat perception. However, little is known about the effects of THC on amygdala reactivity in humans. We used functional magnetic resonance imaging and a well validated task to probe amygdala responses to threat signals in 16 healthy, recreational cannabis users after a double-blind crossover administration of THC or placebo. We found that THC significantly reduced amygdala reactivity to social signals of threat but did not affect activity in primary visual and motor cortex. The current findings fit well with the notion that THC and other cannabinoids may have an anxiolytic role in central mechanisms of fear behaviors and provide a rationale for exploring novel therapeutic strategies that target the cannabinoid system for disorders of anxiety and social fear.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available